<?xml version="1.0" encoding="UTF-8"?>

<SubstanceDefinition xmlns="http://hl7.org/fhir">
  <id value="substance-dolutegravirsodium"/>
  <meta>
    <profile value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/SubstanceDefinition-uv-epi"/>
  </meta>
  <text>
    <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: SubstanceDefinition</b><a name="substance-dolutegravirsodium"> </a><a name="hcsubstance-dolutegravirsodium"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource SubstanceDefinition &quot;substance-dolutegravirsodium&quot; </p><p style="margin-bottom: 0px">Profile: <a href="https://build.fhir.org/ig/HL7/emedicinal-product-info//StructureDefinition-SubstanceDefinition-uv-epi.html">SubstanceDefinition (ePI)</a></p></div><p><b>identifier</b>: <code>https://gsrs.ncats.nih.gov/ginas/app/beta/</code>/1Q1V9V5WYQ (use: OFFICIAL)</p><p><b>version</b>: 1</p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://hl7.org/fhir/R5/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>manufacturer</b>: <a href="Organization-man-173fde4cb6b1018cb7ec8ab708d3961c.html">Organization/man-173fde4cb6b1018cb7ec8ab708d3961c</a> &quot;GLAXO WELLCOME, S.A.&quot;</p><h3>MolecularWeights</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Amount</b></td></tr><tr><td style="display: none">*</td><td>exact <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> ()</span></td><td>441.36</td></tr></table><h3>Structures</h3><table class="grid"><tr><td style="display: none">-</td><td><b>MolecularFormula</b></td></tr><tr><td style="display: none">*</td><td>C20H18F2N305.Na</td></tr></table><h3>Names</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Name</b></td><td><b>Type</b></td></tr><tr><td style="display: none">*</td><td>(4R,12.ALPHA.S)-N-((2,4-DIFLUOROPHENYL)METHYL)-7-HYDROXY-4-METHYL-6,8-DIOXO-3,4,6,8,12,12.ALPHA.-HEXAHYDRO-2H-PYRIDO(1',2':4,5)PYRAZINO(2,1-.BETA.)(1,3)OXAZINE-9-CARBOXAMIDE</td><td>Chemical Name <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#x)</span></td></tr></table></div>
  </text>
  <identifier>
    <use value="official"/>
    <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
    <value value="1Q1V9V5WYQ"/>
  </identifier>
  <version value="1"/>
  <status>
    <coding>
      <system value="http://hl7.org/fhir/publication-status"/>
      <code value="active"/>
    </coding>
  </status>
  <manufacturer>
    <reference value="Organization/man-173fde4cb6b1018cb7ec8ab708d3961c"/>
  </manufacturer>
  <molecularWeight>
    <type>
      <text value="exact"/>
    </type>
    <amount>
      <value value="441.36"/>
    </amount>
  </molecularWeight>
  <structure>
    <molecularFormula value="C20H18F2N305.Na"/>
  </structure>
  <name>
    <name value="(4R,12.ALPHA.S)-N-((2,4-DIFLUOROPHENYL)METHYL)-7-HYDROXY-4-METHYL-6,8-DIOXO-3,4,6,8,12,12.ALPHA.-HEXAHYDRO-2H-PYRIDO(1',2':4,5)PYRAZINO(2,1-.BETA.)(1,3)OXAZINE-9-CARBOXAMIDE"/>
    <type>
      <coding>
        <system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
        <code value="x"/>
        <display value="Chemical Name"/>
      </coding>
    </type>
  </name>
</SubstanceDefinition>